Page last updated: 2024-10-31

muscimol and Demyelinating Diseases

muscimol has been researched along with Demyelinating Diseases in 1 studies

Muscimol: A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies.
muscimol : A member of the class of isoxazoles that is 1,2-oxazol-3(2H)-one substituted by an aminomethyl group at position 5. It has been isolated from mushrooms of the genus Amanita.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research Excerpts

ExcerptRelevanceReference
"Bicuculline treatment significantly reduced demyelination extension and increased the level of MBP expression."1.48Inhibition of GABA A receptor improved spatial memory impairment in the local model of demyelination in rat hippocampus. ( Afghani, A; Ashrafpour, M; Ashrafpour, S; Dehghan, S; Ebrahim Tabar, F; Gol, M; Mousavi Majd, A; Pourabdolhossein, F, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mousavi Majd, A1
Ebrahim Tabar, F1
Afghani, A1
Ashrafpour, S1
Dehghan, S1
Gol, M1
Ashrafpour, M1
Pourabdolhossein, F1

Other Studies

1 other study available for muscimol and Demyelinating Diseases

ArticleYear
Inhibition of GABA A receptor improved spatial memory impairment in the local model of demyelination in rat hippocampus.
    Behavioural brain research, 2018, 01-15, Volume: 336

    Topics: Animals; Avoidance Learning; Bicuculline; Demyelinating Diseases; Disease Models, Animal; GABA-A Rec

2018